Downside #2: Management and Expenses The injectable form of semaglutide requires a weekly injection, which can prove bothersome for some people [12]
Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss Among Adults Without Diabetes: A Systematic Review of Randomized Controlled Trials
This steady glucose response encourages ongoing GLP-1 release in your gut, complementing your medication and keeping you feeling full longer
Individual Metabolism Metabolism varies and affects how fast and how much you lose weight
Additionally, semaglutide has been associated with an increased risk of certain thyroid tumors in animal studies, although it is unclear if this risk translates to humans
Early side effects are predominantly gastrointestinal including nausea, vomiting, and changes in bowel habit and are managed through a gradual, pre-specified dose-escalation schedule